Author at Microdose

Nicolle Hodges

Nicolle Hodges is a Toronto-based journalist, author, sexual freedom philosopher. Hodges, a former CTV Vancouver television host and producer, left her previous life to pursue the world of sex, psychedelics, and shedding shame. Staying true to her media roots, she became the culture editor for Herb, an independent journalist for DoubleBlind, and host of The Dales Report — a media platform offering investment strategies for traders focused on psychedelics, cannabis, and crypto. In 2017, she launched Men Who Take Baths, a men’s mental health movement addressing masculinity, vulnerability, and gender equity. Hodges holds intimate conversations with men, interviewing them on what it means to “be a man” as her guest sits in a bubble bath. She is also the founder of Girls Who Say Fuck, a pleasure-centric incubator for ideas that instigate change. Here, she launched a viral movement urging people to rebrand “virginity” to “sexual debut,” pushing back against heteronormative, patriarchal ideas of sexual expression and towards female empowerment. Her debut book, “Oh, the Places You’ll Go Oh Oh,” explores the power of female orgasms through Dr. Suess-style rhyme and illustration. Hodges is currently pursuing her BA in Psychology at York University with the intention to become a psychedelic-assisted therapist.

Conscious Collective

The viewpoints shared are exclusively those of the contributor and do not necessarily represent the perspectives of Microdose's editorial team or its publishers.

Culture

14 Feb 2023

Valentine’s Day Perspective: Sex and Psychedelics

To help celebrate Valentine's Day, we're re-posting this piece on Sex & Psychedelics from Nicolle Hodges....

By Nicolle Hodges

Culture

14 Mar 2022

Sex & Psychedelics: Altering Our States of Consciousness

BDSM, not unlike psychedelics, can facilitate an altered state of consciousness...

By Nicolle Hodges

Culture

14 Feb 2022

Sex & Psychedelics Series: Owning Desire

For Valentine's Day, we're re-posting Nicolle Hodge's Sex & Psychedelics column....

By Nicolle Hodges

Conscious Collective

The viewpoints shared are exclusively those of the contributor and do not necessarily represent the perspectives of Microdose's editorial team or its publishers.

Follow us on social

Latest News

You Might Also Like

26 Nov 2025

Delix Therapeutics Reports Strong Phase Ib Results

Delix Therapeutics recently announced compelling data from a Phase Ib trial of DLX-001 (zalsupindole), a non-hallucinogenic neuroplastogen. According to the company’s release, DLX-001 produced robust biomarker signals (quantitative EEG and...

By Madison Roberts

19 Nov 2025

Childhood Trauma’s Role in Men’s Substance Use Disorders

Childhood trauma leaves a deeper imprint on men’s lives than most realize—and for many, it becomes the hidden engine driving substance use disorders. Research shows that emotional abuse, physical violence,...

By Madison Roberts

19 Nov 2025

Human-Centered AI in Healthcare

Artificial intelligence is redefining modern healthcare, offering powerful tools that enhance diagnosis, expedite drug discovery, and enable truly personalized treatment. As health systems struggle with rising costs, aging populations, and...

By Madison Roberts

16 Oct 2025

Enveric Biosciences Doubles Down on IP Strength as Psychedelic Biotech Sector Heats Up

As Big Pharma makes billion-dollar bets in the evolving landscape of neuropsychiatric therapeutics, Enveric Biosciences (NASDAQ: ENVB) is carving out a formidable position — not by chasing headlines, but by...

By Madison Roberts

15 Oct 2025

The IP Battle Behind the $1.2B Psychedelic Acquisition—and Why Enveric Biosciences Is a Name to Watch

Take Enveric Biosciences (NASDAQ: ENVB), a company that’s been flying under the radar while building an IP fortress around a novel class of non-hallucinogenic neuroplastogens. Now, that fortress is being...

By Madison Roberts

10 Oct 2025

After the Billion-Dollar Psychedelic Bet: Who’s Next for Big Pharma?

In the wake of Gilgamesh’s billion-dollar exit, a new wave of companies is emerging, smaller, stealthier, and far more scientifically disciplined than their first-wave predecessors. Their mission: harness the therapeutic...

By Madison Roberts

Nicolle Hodges is a Toronto-based journalist, author, sexual freedom philosopher. Hodges, a former CTV Vancouver television host and producer, left her previous life to pursue the world of sex, psychedelics, and shedding shame. Staying true to her media roots, she became the culture editor for Herb, an independent journalist for DoubleBlind, and host of The Dales Report — a media platform offering investment strategies for traders focused on psychedelics, cannabis, and crypto. In 2017, she launched Men Who Take Baths, a men’s mental health movement addressing masculinity, vulnerability, and gender equity. Hodges holds intimate conversations with men, interviewing them on what it means to “be a man” as her guest sits in a bubble bath. She is also the founder of Girls Who Say Fuck, a pleasure-centric incubator for ideas that instigate change. Here, she launched a viral movement urging people to rebrand “virginity” to “sexual debut,” pushing back against heteronormative, patriarchal ideas of sexual expression and towards female empowerment. Her debut book, “Oh, the Places You’ll Go Oh Oh,” explores the power of female orgasms through Dr. Suess-style rhyme and illustration. Hodges is currently pursuing her BA in Psychology at York University with the intention to become a psychedelic-assisted therapist.

Conscious Collective

The viewpoints shared are exclusively those of the contributor and do not necessarily represent the perspectives of Microdose's editorial team or its publishers.

Conscious Collective

The viewpoints shared are exclusively those of the contributor and do not necessarily represent the perspectives of Microdose's editorial team or its publishers.

Follow us on social

WordPress Ads